Orly Avnery

Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation

R. Arbel, A. Hammerman, D. Greenberg, 2019, Heart.

Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome—Multicenter, Real-Life Long-Term Follow-Up

N. Agmon-Levin, M. Rapoport, M. Ellis, 2022, Frontiers in Immunology.

Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome

N. Agmon-Levin, M. Ellis, A. Lubetsky, 2022, Frontiers in Pharmacology.

Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based study.

A. Hammerman, E. Derazne, E. Battat, 2018, Thrombosis research.

A Genetic Origin? Purpura Fulminans.

G. Kenet, M. Ellis, Orly Avnery, 2019, The American journal of medicine.

Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial Fibrillation.

R. Arbel, A. Hammerman, R. Sergienko, 2019, The American journal of medicine.